 | CRISPR Therapeutics (NASDAQ:CRSP) Stock Rating Reaffirmed by Barclays
marketbeat.com - March 1 at 12:15 AM |
| 3 Groundbreaking Genomics Stocks to Buy Now
marketbeat.com - January 8 at 6:58 PM |
| 3 Biotech Stocks to Watch in December (CRSP)
marketbeat.com - December 1 at 5:22 PM |
 | Is CRISPR Stock Heading to $160 in 2021?
finance.yahoo.com - March 4 at 5:53 PM |
 | CRISPR Therapeutics (NASDAQ:CRSP) Now Covered by Analysts at JMP Securities
americanbankingnews.com - March 4 at 2:01 PM |
 | Anthem, BioMarin, CRISPR, GE and More Thursday Afternoon Analyst Calls
247wallst.com - March 4 at 12:52 PM |
| CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 8.2%
americanbankingnews.com - March 3 at 8:26 PM |
| Barclays Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $140.00
americanbankingnews.com - March 1 at 8:33 AM |
| CRISPR Therapeutics (NASDAQ:CRSP) Rating Reiterated by Barclays
americanbankingnews.com - March 1 at 12:50 AM |
 | CRISPR Therapeutics: Roadblock Ahead
seekingalpha.com - February 25 at 3:17 PM |
| CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 7%
americanbankingnews.com - February 22 at 9:20 PM |
| Q1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Decreased by Analyst
americanbankingnews.com - February 21 at 1:42 AM |
|
| Q1 2021 Earnings Estimate for CRISPR Therapeutics AG Issued By William Blair (NASDAQ:CRSP)
americanbankingnews.com - February 21 at 1:42 AM |
| Q1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Lowered by Truist Securiti
americanbankingnews.com - February 19 at 7:22 AM |
| Q1 2021 EPS Estimates for CRISPR Therapeutics AG Reduced by Analyst (NASDAQ:CRSP)
americanbankingnews.com - February 19 at 7:22 AM |
| The Goldman Sachs Group Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $189.00
americanbankingnews.com - February 17 at 6:00 PM |
| Wall Street Looks Again at Bluebird, Rivals, After Gene-Therapy Setback
finance.yahoo.com - February 17 at 9:05 AM |
| CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $187.00 at Oppenheimer
americanbankingnews.com - February 17 at 9:02 AM |
| Chardan Capital Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $175.00
americanbankingnews.com - February 17 at 9:02 AM |
 | Interesting CRSP Put And Call Options For April 1st
nasdaq.com - February 11 at 4:10 PM |
| Bear of the Day: CRISPR Therapeutics (CRSP)
finance.yahoo.com - February 11 at 11:09 AM |
| Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day
finance.yahoo.com - February 11 at 11:09 AM |
| CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
finance.yahoo.com - February 5 at 10:24 AM |
| CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 5 at 10:24 AM |
| CRSP Feb 2021 155.000 call
au.finance.yahoo.com - February 2 at 5:54 PM |
| CRSP Jul 2021 75.000 put
au.finance.yahoo.com - February 2 at 5:54 PM |
| Vertex Stock Dips On Mixed Report; Investors Eye Its Next Catalysts
finance.yahoo.com - February 1 at 7:56 PM |
| CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer
finance.yahoo.com - February 1 at 9:55 AM |
 | CRSP Jan 2022 310.000 call
uk.finance.yahoo.com - January 23 at 2:21 PM |
| CRSP Jan 2021 177.500 put
uk.finance.yahoo.com - January 23 at 2:21 PM |
| The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticals
finance.yahoo.com - January 11 at 11:26 AM |
| 3 Top Biotech Stocks To Put On Your January 2021 Watchlist
nasdaq.com - January 8 at 7:31 PM |
| Genetics Stocks Pop After Intellia Offers Update For Gene-Editing Drugs
finance.yahoo.com - January 7 at 3:00 PM |
| 3 Biotech Technological Developments to Watch Out For in 2021
finance.yahoo.com - January 7 at 9:54 AM |
|
| CRISPR Therapeutics Is Still Looking Strong
finance.yahoo.com - January 6 at 6:48 PM |
 | Thinking about trading options or stock in Crispr Therapeutics, GameStop, Moderna, Tesla, or FuelCell Energy?
marketwatch.com - December 29 at 7:47 PM |
| Interesting CRSP Put And Call Options For February 2021
nasdaq.com - December 24 at 2:30 PM |
| Intellia Therapeutics: The Smallest Of The Big 3 CRISPR Companies Has Big Potential
seekingalpha.com - December 23 at 1:37 PM |
| Cutting Edge CRISPR Therapeutics Has Cut a Path Higher
finance.yahoo.com - December 22 at 5:06 PM |
 | Return On Capital Employed Overview: CRISPR Therapeutics
benzinga.com - December 22 at 12:06 PM |
| 5 Medical Outperformers That Might Lose Steam in 2021
finance.yahoo.com - December 22 at 12:06 PM |
| First Week of CRSP February 2021 Options Trading
nasdaq.com - December 21 at 12:56 PM |
| Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives
finance.yahoo.com - December 21 at 12:56 PM |
 | Up 140% YTD, is CRISPR Therapeutics Still a Buy?
stocknews.com - December 18 at 10:14 AM |
| Megatrends To Invest In Now: 3 Best ETF Picks
finance.yahoo.com - December 16 at 2:28 PM |
| Growth Investors: Industry Analysts Just Upgraded Their CRISPR Therapeutics AG (NASDAQ:CRSP) Revenue Forecasts By 10%
nasdaq.com - December 16 at 9:27 AM |
| Where Will CRISPR Therapeutics Be in 10 Years?
finance.yahoo.com - December 15 at 8:53 AM |
| CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
finance.yahoo.com - December 14 at 12:52 PM |
| Crispr Therapeutics Deserves Attention After Positive CRISPR/Cas9 Patient Data
seekingalpha.com - December 11 at 12:28 PM |
| CRISPR Therapeutics AG (CRSP) Phase 1/2 CTX001 Investor Update (Transcript)
seekingalpha.com - December 11 at 2:25 AM |
| Are Options Traders Betting on a Big Move in CRISPR Therapeutics (CRSP) Stock?
finance.yahoo.com - December 8 at 4:38 PM |
| CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of Medicine
finance.yahoo.com - December 5 at 4:00 PM |
| CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)
seekingalpha.com - December 2 at 6:03 PM |
